Fagron Sa

Pete Pharma and Fagron Enter Strategic Distribution Partnership to Expand Access to Pharmaceutical 3D Printing Across North America

Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026

Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth

Fagron increases share capital through exercise subscription rights

Fagron publishes its Annual Report 2025